» Articles » PMID: 20004666

Minicircle Performance Depending on S/MAR-nuclear Matrix Interactions

Overview
Journal J Mol Biol
Publisher Elsevier
Date 2009 Dec 17
PMID 20004666
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

The ideal vector for cell and tissue modification does not depend on integration but rather behaves as an independent functional unit that replicates as an episome. Based on a scaffold/matrix attachment region (S/MAR), we have introduced, in 2006, an approximately 4-kb replicating nonviral minicircle able to exploit the cellular replication machinery in a way reminiscent of ARS vectors. Consisting of only one active transcription unit and the S/MAR, it resists silencing as it is free of prokaryotic vector parts and drug selection markers. The rate of final establishment in the nuclear architecture is moderate but comparable to Epstein-Barr virus-based episomes (<5%). Here, we demonstrate that this parameter can be improved if the host cell chromatin is opened by histone hyperacetylation prior to transfection. It remains unaffected, however, by cell cycle position. Still, this class of episomes revealed intrinsic instability and integration after 5 months of continuous culture. In vivo evolution enabled the effective reduction of S/MAR size from 2 kb to 733 bp (resulting in a minicircle of approximately 3 kb) with largely improved stability and cloning capacity. Investigation of individual clones served to prove persistent and homogenous expression, which is ascribed to stable association with nuclear attachment sites. Optimum expression levels were shown to depend on the authentic usage of a polyadenylation site 3' from the S/MAR as anticipated by the stress-induced duplex destabilization algorithm, which finds increasing use to predict the functional parameters of these systems.

Citing Articles

In Vivo Selection of S/MAR Sequences to Favour AAV Episomal Maintenance in Dividing Cells.

Llanos-Ardaiz A, Lantero A, Neri L, Mauleon I, Ruiz de Galarreta M, Trigueros-Motos L Int J Mol Sci. 2024; 25(23).

PMID: 39684442 PMC: 11641770. DOI: 10.3390/ijms252312734.


Non-Viral Episomal Vector Mediates Efficient Gene Transfer of the β-Globin Gene into K562 and Human Haematopoietic Progenitor Cells.

Lazaris V, Simantirakis E, Stavrou E, Verras M, Sgourou A, Keramida M Genes (Basel). 2023; 14(9).

PMID: 37761914 PMC: 10530965. DOI: 10.3390/genes14091774.


Episomes and Transposases-Utilities to Maintain Transgene Expression from Nonviral Vectors.

Kreppel F, Hagedorn C Genes (Basel). 2022; 13(10).

PMID: 36292757 PMC: 9601623. DOI: 10.3390/genes13101872.


Advances in the Development and the Applications of Nonviral, Episomal Vectors for Gene Therapy.

Mulia G, Picanco-Castro V, Stavrou E, Athanassiadou A, Figueiredo M Hum Gene Ther. 2021; 32(19-20):1076-1095.

PMID: 34348480 PMC: 8819515. DOI: 10.1089/hum.2020.310.


Episomal vectors based on S/MAR and the β-globin Replicator, encoding a synthetic transcriptional activator, mediate efficient γ-globin activation in haematopoietic cells.

Stavrou E, Simantirakis E, Verras M, Barbas 3rd C, Vassilopoulos G, Peterson K Sci Rep. 2019; 9(1):19765.

PMID: 31874995 PMC: 6930265. DOI: 10.1038/s41598-019-56056-z.